Navigation Links
Human Genome Sciences Announces Positive Final Results Of Phase 2b,Trial of Albuferon

response offered by the 1200-microgram dose on a two-week administration schedule," said Dr. Stump.

    Albuferon 1200-mcg Monthly (Albuferon 1200 Q4w)


    -- ITT analysis shows that 50.9% of patients in the Albuferon 1200 Q4w

       treatment group achieved SVR, vs. 57.9% for Pegasys administered every

       week.

    -- In heavier patients (>75 kg) who were treatment-adherent, 61.0% of

       those in the Albuferon 1200 Q4w treatment group achieved SVR, versus

       53.3% for Pegasys administered once every week.

    -- Among all treatment-adherent patients in the Albuferon 1200 Q4w

       treatment group, 62.0% achieved SVR, versus 66.7% for Pegasys.

    -- The rate of discontinuations due to adverse events was 12.1% in the

       Albuferon 1200 Q4w treatment group, vs. 6.1% in the Pegasys group.

    -- The number of patients experiencing severe hematologic adverse events

       was significantly lower in the Albuferon 1200 Q4w treatment group

       (10.3%, vs. 23.7% for Pegasys, p=0.006).

"We are encouraged that more than half of the patients achieved sustained virologic response in the treatment group receiving Albuferon 1200-mcg once every month," said Dr. Stump. "These data, along with emerging Phase 2 data for a monthly 1500-mcg dose, provide an excellent rationale for the study that we and our collaborator, Novartis, are currently planning to evaluate higher doses of Albuferon administered monthly."

The top-line final Phase 2b results include data through Week 24 following completion of 48 weeks of therapy. The open-label, multi-center, active- controlled, dose-ranging trial enrolled and randomized 458 patients with genotype 1 chronic hepatitis C. Patients were randomized into four treatment groups, three of which received subcutaneously administered Albuferon (900 mcg every two weeks, 1200 mcg every two weeks, and 1200 mcg every four weeks). The fourth treatment group served as the active control group and recei
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Testing for Human Papillomavirus
2. Bio-Matrix Scientifics Dr. ONeill Sees University of Pittsburghs Published Study on Culture Blood-Forming Stem Cells from Human Fat Tissue as Supporting Near Term Benefits of Banking Adipose (Fat) Derived Stem Cells
3. Phase II Results Show Once-Daily Dosing of Human GLP-1 Analog Liraglutide, Brings Patients to A1c Target
4. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
5. Modigene Announces Successful Completion of Pharmacokinetic & Pharmacodynamic Pre-Clinical Experiments for Proprietary Long-Acting Human Growth Hormone, Long-acting Interferon Beta and Long-acting Erythropoietin
6. Second Successful Quigley QR-443 Study Suggests Method of Action Relevant to Broad Range of Chronic Inflammatory Diseases - Human Study to Follow -
7. Research Documents Scalable Production, Survival Following Engraftment and Positive Impact on Cardiac Function in Infarcted Rats for Gerons Human Embryonic Stem Cell-Based Therapeutic for Heart Failure
8. Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B Showed Significant Reductions in Disease Activity in Patients with Active Systemic Lupus Erythematosus
9. NCI Researchers Discover Genes That Are Turned on at High Levels in Tumor-associated Blood Vessels of Mice and Humans
10. Research Indicates Gerons Human Embryonic Stem Cell-Based Therapeutic for Spinal Cord Injury Evades Direct Attack by the Human Immune System
11. Mymetics HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model
Post Your Comments:
(Date:9/3/2015)... 03, 2015 Research ... addition of the "Global Craniomaxillofacial (CMF) Devices ... The global craniomaxillofacial devices market to grow ... This report covers the present and future scenario ... To calculate the market size, we use revenues ...
(Date:9/3/2015)... , Sep. 03, 2015 ... the addition of the "Diabetes Care Devices Market ... (Self-Monitoring Blood Glucose Meters, Continuous Glucose Monitors, Testing Strips, ... to 2020" report to their offering. ... be valued at USD 1.7 Billion in 2015 and ...
(Date:9/3/2015)... -- The findings of a year-long investigation conducted by NBC ... handling of its Recovery IVC filter product ... part one of the series revealed that ... fatalities, have been associated with the Recovery device. NBC ... Bard in 2004 which linked the Recovery IVC filter ...
Breaking Medicine Technology:Global Craniomaxillofacial (CMF) Devices Market 2015-2019 - Product Innovation and Cost Reduction a Key Market Trend 2The BRIC Diabetes Care Devices Market is Estimated to Grow at a CAGR of 6.3% from 2015 to 2020, to Reach USD 2.3 Billion by 2020 2The BRIC Diabetes Care Devices Market is Estimated to Grow at a CAGR of 6.3% from 2015 to 2020, to Reach USD 2.3 Billion by 2020 3IVC Filter Lawsuit News: NBC News Investigation into C.R. Bard Recovery Filters Raises Disturbing Questions, Bernstein Liebhard LLP Reports 2IVC Filter Lawsuit News: NBC News Investigation into C.R. Bard Recovery Filters Raises Disturbing Questions, Bernstein Liebhard LLP Reports 3
... Sept. 23 As technologies for fat removal become ... not only reshaping the body but also recycling the ... to the most recent statistics from the American Society ... are among the two most popular invasive and non-invasive ...
... (OTC Bulletin Board: CONX ), a worldwide developer ... year Form 10-K and reported financial results. The report disclosed ... year ended June 30, 2010. Some of the results highlighted ... for the year was $815,981 vs. $403,741 for the prior ...
Cached Medicine Technology:The New Face of Body Contouring 2Corgenix Reports Fiscal 2010 Financial Results 2Corgenix Reports Fiscal 2010 Financial Results 3
(Date:9/3/2015)... Angeles, CA (PRWEB) , ... September 03, 2015 , ... ... patients as to the best practices when preparing for a bariatric procedure, some patients ... a procedure. Apart from the basic instructions typical for many types of surgery that ...
(Date:9/3/2015)... , ... September 03, 2015 , ... ... , a privately held medical technology company that will bring low-cost cancer pre-screening ... worldwide. , Preora’s proprietary and automated technology platform detects and measures cellular ...
(Date:9/3/2015)... Manchester, NH (PRWEB) , ... September 03, 2015 ... ... a new agreement with Amerinet Inc., a leading national healthcare solutions organization, to ... to Epic EMR. , Through this agreement, Amerinet members will receive negotiated pricing ...
(Date:9/3/2015)... (PRWEB) , ... September 03, 2015 , ... ... he made the company the final destination of his six-month, 10,000 mile journey ... , During the trek—which he calls the “Connecting Las Americas” project—Max crossed ...
(Date:9/3/2015)... ... September 03, 2015 , ... Results of a comprehensive ... Research and Policy Analysis has found physician leadership development training programs to be ... of respondents said their organizations conduct some kind of physician leadership development program, ...
Breaking Medicine News(10 mins):Health News:Dr. Feiz and Associates Answer August's ‘Patient Submitted Question of the Month’: “How Can I Prepare for Weight Loss Surgery” 2Health News:Preora Diagnostics to Commercialize Cancer Pre-screening Tests 2Health News:Preora Diagnostics to Commercialize Cancer Pre-screening Tests 3Health News:E-Volve Health to Offer EMR Consulting Solutions to Amerinet Members 2Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 2Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 3Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 4Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 5Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 6Health News:Survey finds growing movement for physician leadership training 2Health News:Survey finds growing movement for physician leadership training 3
... studies published in the August issue of Pediatrics, researchers have ... posed increased health hazards to small children. ,Lead researcher ... and Policy at Columbus Children's Hospital in Ohio said that ... adults primarily for the convenience of adults, and the safety ...
... algae to be a potent inhibitor of Human Papillomavirus (HPV) ... has been published in the July issue of PLoS Pathogens. ... Human Papillomavirus (HPV) from sticking to the cells and prevents ... natural and less expensive way to block cervical cancer than ...
... A court in Fiji has awarded $458,755 in compensation to ... being administered// excessive oxygen in an incubator post-birth. ,Jashnil ... a hospital in Lautoka, northwestern Fiji, was kept in an ... Fiji Times newspaper. ,Kamni Devi, the boy's mother, ...
... John Neal, 48, of Coburg, Melbourne, who is HIV positive, ... have been heaped on him//. The fear of using condoms ... male partners and thus became a transmitter of the disease. ... with 30 or more charges, which also includes a grave ...
... of people who suffer from chronic allergies to pets, ... develop Parkinson’s disease later in life. ,A ... shown that people who suffer from allergic rhinitis, which ... ‘permanent cold’, are probably at a greater risk of ...
... to separate four-year-old conjoined twin girls, surgeons in the US ... separate their liver. ,The operation in Salt Lake City ... who share a kidney. Kendra and Maliyah Herrin are joined ... ,If the surgery at Primary Children's Hospital is successful, ...
Cached Medicine News:Health News:Health Hazards Faced By Small Children 2Health News:New Cancer-Blocking Algae Found 2Health News:Fiji Boy Compensated for Losing Eye-sight due to Medical Lapse 2Health News:Researchers Hint At The Probability Of A Link Between Rhinitis And Parkinson’ 2Health News:Researchers Hint At The Probability Of A Link Between Rhinitis And Parkinson’ 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: